Coming November 4: ASH publishes its abstracts and its oral and poster sessions. We’ll add the institutions presenting them as they become publicly available.

Syndax Pharmaceuticals at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Syndax Pharmaceuticals exhibits at Booth 3539 at ASH 2026 in New Orleans. Syndax Pharmaceuticals supports a symposium on precision treatment decisions in acute myeloid leukemia. Experts debate frontline therapy, targeted agents and how to sequence them across the course of care.

OrganizationASH 2026 Attendance
syndax.com
Biotech1 exhibitor meeting room
Commercial-stage biotech with a menin inhibitor for relapsed or refractory acute leukemia and a CSF-1 receptor antibody for chronic GVHD.
Booth
Exhibiting at Booth 3539
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
Medical Crossfire®: Precision Decisions in AML – Experts Debating Frontline Therapy, Targeted Agents, and Sequencing Across Care
Frontline therapy, targeted drugs, and treatment sequencing in acute myeloid leukemia, framed around real questions from community oncologists.
Convention Center · Great Hall AD
Leukemias

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Syndax Pharmaceuticals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction